EFTA-Canada FTA – Origin Cumulation Pharmaceutical Products

Quelle: https://www.efta.int/

Origin cumulation refers to the practice wherein the origin of goods in a trade agreement is determined such that products from the EFTA region and Canada can collectively be considered as originating, especially for pharmaceutical products.

Related Terms

You might also be interested in these terms

EFTA-Canada FTA

The EFTA-Canada FTA is a free trade agreement between the European Free Trade Association (EFTA) and Canada that reduces tariffs and trade barriers to...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

CETA EU–Canada – Origin Cumulation Pharmaceutical Products

Under CETA, origin cumulation allows for the consideration of the actual origins of inputs from the EU and Canada in the determination of the origin o...

Learn more

EFTA-Canada FTA - Origin Cumulation Shoes

The origin cumulation under the EFTA-Canada Free Trade Agreement (FTA) allows materials and components of either domestic or foreign origin used in th...

Learn more